Archive for the ‘Colorectal Cancer’ Category

Biothera Drug Synergistic With Avastin(R) Against Cancer, Study Finds

Monday, March 3rd, 2008

Biothera's Imprime PGG™ increased the effectiveness of Avastin(R) (bevacizumab), a monoclonal antibody approved for the treatment of metastatic colorectal, breast and non-small cell lung cancer, according to a new preclinical study published in the current issue of Clinical Cancer Research. Researchers in the Tumor Immunobiology Program of the James Graham Brown ...

A Novel HMSH2 Gene Mutation In Colorectal Cancer Patients?

Monday, February 25th, 2008

About 20% CRC patients have a genetic component and HNPCC is the most common autosomal dominant hereditary syndrome. Some Chinese HNPCC pedigrees were recently reported in the World Journal of Gastroenterology because of their great significance for hereditary CRC. This article will undoubtedly bring comfort to many families. The article describes ...

FDA Clears Advanced Test For Monitoring Metastatic Colorectal Cancer

Friday, November 23rd, 2007

Veridex, LLC announced that the U.S. Food and Drug Administration (FDA) has granted an expanded clearance for the CellSearch™ System to be used as an aid in the monitoring of metastatic colorectal cancer. CellSearch™ is currently approved for monitoring metastatic breast cancer. The CellSearch™ System identifies and counts circulating tumor cells ...

Some Clinicians Recommend Repeat Colonoscopies Too Soon

Thursday, November 1st, 2007

Colonoscopies are important screening tools to find colon cancers, but a recent study implies that endoscopists suggest repeat tests more often than practice guidelines recommend. Alex Krist, M.D., assistant professor in the department of family medicine at Virginia Commonwealth University Medical Center in Richmond, and colleagues reviewed the medical charts of ...

ACOG Announces Change In Colorectal Cancer Screening Recommendations For Women

Monday, October 29th, 2007

The American College of Obstetricians and Gynecologists (ACOG) announced new recommendations emphasizing colonoscopy as the preferred method for colorectal cancer screening for both average-risk and high-risk women. ACOG is the first and only primary care organization to recommend colonoscopy as the preferred screening method for colorectal cancer. ACOG's new recommendations ...

Study Points To A Possible Biomarker For Colon Cancer In People 50 And Under

Monday, October 29th, 2007

An abnormality of chromosomes long associated with diseases of aging has, for the first time, been linked to colon cancer in people 50 years old and younger, an age group usually considered young for this disease. The finding may provide an early alert for younger patients with colon cancer and could ...

Colonoscopy Remains The Most Effective Screening Option For Colon Cancer

Thursday, October 25th, 2007

OAK BROOK, Ill. — According to the American Society for Gastrointestinal Endoscopy (ASGE), colonoscopy remains the most effective screening option for colorectal cancer. Colonoscopy is widely accepted as the best method for colon cancer screening because it allows the trained physician to thoroughly evaluate the entire colon. Colonoscopy has a ...

Biothera Initiates Phase Ib/IIa Clinical Trial With Imprime PGG And Erbitux In Metastatic Colorectal Cancer Patients

Thursday, October 25th, 2007

EAGAN, Minn. — Biothera announced today that it has initiated enrollment of patients in a phase Ib/IIa clinical trial to evaluate the safety and efficacy of Imprime PGG(TM) and Erbitux(R) in patients with metastatic colorectal cancer. Imprime PGG is a unique biological response modifier that enhances specific innate immune cell ...

Could my biopsy results be wrong?

Tuesday, October 23rd, 2007

I’ve had one enlarged lymph node on the left side of my neck for about a year, didn’t think much of it. 2 months ago, one right under it swelled. I had a needle biopsy done, negative lymphoma. Now I have a group of them (5) surrounding the initial one, ...